Skip to main content
Livermore
Livermore
ZHEN

Accelerate Diagnostics, Inc

AXDXDelisted Jul 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0000727207

Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.

13F holders, Q3 2025

Institutional positions in Accelerate Diagnostics, Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

AXDX is no longer listed, and 13F filings after Q1 2025 list far fewer holders. See Q1 2025

Institutional holders
0
−3 vs. Q2 2025
Shares held
0
−326.2K (−100.0%) vs. Q2 2025
Total value
$0
−$2.08K (−100.0%) vs. Q2 2025
New holders
0
0 more added
Sold out
3
0 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AXDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 0 institutions
Q1 2021: 99 institutionsQ2 2021: 95 institutionsQ3 2021: 105 institutionsQ4 2021: 107 institutionsQ1 2022: 106 institutionsQ2 2022: 75 institutionsQ3 2022: 84 institutionsQ4 2022: 73 institutionsQ1 2023: 67 institutionsQ2 2023: 51 institutionsQ3 2023: 38 institutionsQ4 2023: 43 institutionsQ1 2024: 46 institutionsQ2 2024: 41 institutionsQ3 2024: 46 institutionsQ4 2024: 47 institutionsQ1 2025: 43 institutionsQ2 2025: 3 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2025: $0
Q1 2021: $205.1MQ2 2021: $194.7MQ3 2021: $138.2MQ4 2021: $124.7MQ1 2022: $33.1MQ2 2022: $18.6MQ3 2022: $41.2MQ4 2022: $18.0MQ1 2023: $17.2MQ2 2023: $18.0MQ3 2023: $14.7MQ4 2023: $9.78MQ1 2024: $4.55MQ2 2024: $4.98MQ3 2024: $8.20MQ4 2024: $5.69MQ1 2025: $3.10MQ2 2025: $2.08KQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding AXDX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20253$2.08K
Q1 202543$3.10M
Q4 202447$5.69M
Q3 202446$8.20M
Q2 202441$4.98M
Q1 202446$4.55M
Q4 202343$9.78M
Q3 202338$14.7M
Q2 202351$18.0M
Q1 202367$17.2M
Q4 202273$18.0M
Q3 202284$41.2M
Q2 202275$18.6M
Q1 2022106$33.1M
Q4 2021107$124.7M
Q3 2021105$138.2M
Q2 202195$194.7M
Q1 202199$205.1M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Accelerate Diagnostics, Inc; share changes are against Q2 2025.

Institutions holding AXDX in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Birchview Capital, LP0$00.00%−325,239−100.0%Sold out
Bartlett & Co. Wealth Management LLC0$00.00%−100−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−889−100.0%Sold out